Cover Image
市場調查報告書

心臟生物標記的全球市場

Global Cardiac Biomarkers Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 318286
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
心臟生物標記的全球市場 Global Cardiac Biomarkers Market 2014-2018
出版日期: 2014年11月05日 內容資訊: 英文 105 Pages
簡介

心臟生物標記,是作為急性冠狀動脈症候群(ACS)、急性冠狀動脈症候群、心肌梗塞(MI)、心臟衰竭等的心臟疾病(CDV)相關診斷和風險分類所使用的指標可測量的物質。主要的心臟生物標記,有肌酸激酶(CK) MB、肌鈣蛋白(cTnI和cTnT)、BNP、NT-proBNP、 GFAP、H-FABP、LDH同功異構酵素、D-二聚體、IMA、MPO、肌紅蛋白、sCD40L等。全球FPS市場,預計從2013年到2018年的期間年複合成長率成長12.75%。

本報告提供全球心臟生物標記市場相關調查分析、市場概要、市場區隔考察、各地區考察、推動市場的要素與課題、主要企業等相關彙整。

第1章 摘要整理

第2章 簡稱一覽

第3章 報告的範圍

  • 市場概要
  • 商品一覽

第4章 市場調查的方法

  • 市場調查的流程
  • 調查方法

第5章 簡介

第6章 市場概要

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 市場區隔:各檢測類型

第8章 全球肌鈣蛋白檢測市場

  • 簡介
  • 市場概要
  • 市場規模與預測

第9章 全球BNP/NT-proBNP檢測市場

  • 簡介
  • 市場概要
  • 市場規模與預測

第10章 全球CK-MB檢測市場

  • 簡介
  • 市場規模與預測

第11章 全球肌紅蛋白檢測市場

  • 簡介
  • 市場規模與預測

第12章 市場區隔:各終端用戶

  • 全球心臟POC測試市場
  • 全球POC環境的肌鈣蛋白市場
  • 全球POC環境的BNP/NT-proBNP市場

第13章 全球心臟實驗室測試市場

  • 簡介
  • 全球實驗室環境的肌鈣蛋白市場
  • 全球實驗室環境的BNP/NT-proBNP市場

第14章 各地區市場區隔

  • 南北美洲
  • 歐洲/中東/非洲
  • 亞太地區

第15章 主要國家

  • 美國
  • 中國

第16章 購買標準

第17章 市場成長的促進要素

第18章 促進要素與其影響

第19章 市場課題

第20章 促進要素與課題的陰影

第21章 市場趨勢

第22章 趨勢與其影響

第23章 供應商狀況

  • 競爭模式
  • 市場佔有率分析
  • 其他主要供應商

第24章 主要供應商分析

  • Abbott Laboratories
  • Alere
  • Ortho-Clinical Diagnostics
  • Roche Diagnostics
目錄
Product Code: IRTNTR4572

About Cardiac Biomarker

A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, and sCD40L. Cardiac biomarker assays help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in the diagnosis and treatment of CVDs. The abnormal concentration of these biomarkers will act as significant predictors of an adverse cardiovascular condition. Cardiac point of care (POC) testing offers reliable measurement of cardiac biomarkers and provides results within one hour of testing. In addition to saving time, some cardiac POC tests have been modified to improve the accuracy of the measurement of enzymes to reduce operational error.

TechNavio's analysts forecast the Global Cardiac Biomarkers market to grow at a CAGR of 12.75 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Cardiac Biomarkers market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of devices and assays used for cardiac biomarkers to diagnose various cardiovascular diseases.

The market is segmented based on the following type of assay:

  • Troponin (cTnI and cTnT)
  • BNP & NT-proBNP
  • CK-MB
  • Myogloblin

Others (hs-CRP, D-Dimer, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, AST, FFAu, and sCD40L)

TechNavio's report, the Global Cardiac Biomarkers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cardiac Biomarkers market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Alere
  • Ortho Clinical Diagnostics
  • Roche Diagnostics

Other Prominent Vendors

  • AniBiotech
  • Axis-Shield
  • Beckman Coulter
  • Becton, Dickinson and Co.
  • BG Medicine
  • Biomerieux
  • Boston Scientific
  • Critical Diagnostics
  • diaDexus
  • LifeSign
  • Mitsubishi Chemical Europe
  • Nanomix
  • Radiometer Medical
  • Randox Laboratories
  • Response Biomedical
  • Siemens Healthcare
  • Sierra Resources International
  • Singulex
  • Thermo Scientific
  • Trinity Biotech

Market Driver

  • Growing Incidence of Cardiac Disorders
  • For a full, detailed list, view our report

Market Challenge

  • Lack of Specific Measures to Detect Presence of CVDs
  • For a full, detailed list, view our report

Market Trend

  • Identification of New Cardiac Biomarkers
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Type of Assay

08. Global Troponin Assay Market

  • 08.1. Introduction
  • 08.2. Market Overview
  • 08.3. Market Size and Forecast

09. Global BNP & NT-proBNP Assay Market

  • 09.1. Introduction
  • 09.2. Market Overview
  • 09.3. Market Size and Forecast

10. Global CK-MB Assay Market

  • 10.1. Introduction
  • 10.2. Market Size and Forecast

11. Global Myogloblin Assay Market

  • 11.1. Introduction
  • 11.2. Market Size and Forecast

12. Market Segmentation by End-user

  • 12.1. Global Cardiac POC Testing Market
    • 12.1.1. Introduction
    • 12.1.2. Market Overview
    • 12.1.3. Market Size and Forecast
    • 12.1.4. Geographical Segmentation
  • 12.2. Global Troponin Market in POC Setting
    • 12.2.1. Market Overview
    • 12.2.2. Market Size and Forecast
  • 12.3. Global BNP & NT-proBNP Market in POC Setting
    • 12.3.1. Market Overview
    • 12.3.2. Market Size and Forecast

13. Global Cardiac Laboratory Testing Market

    • 13.1.1. Introduction
    • 13.1.2. Market Overview
    • 13.1.3. Market Size and Forecast
    • 13.1.4. Geographical Segmentation
  • 13.2. Global Troponin Market in Laboratory Setting
    • 13.2.1. Market Overview
    • 13.2.2. Market Size and Forecast
  • 13.3. Global BNP & NT-proBNP Market in Laboratory Setting
    • 13.3.1. Market Overview
    • 13.3.2. Market Size and Forecast

14. Geographical Segmentation

  • 14.1. Cardiac Biomarkers Market in the Americas
    • 14.1.1. Market Size and Forecast
    • 14.1.2. Cardiac Biomarkers Market in the US
  • 14.2. Cardiac Biomarkers Market in the EMEA Region
    • 14.2.1. Market Size and Forecast
    • 14.2.2. Cardiac Biomarkers Market in Europe
  • 14.3. Cardiac Biomarkers Market in the APAC Region
    • 14.3.1. Market Size and Forecast
    • 14.3.2. Cardiac Biomarkers Market in China

15. Key Leading Countries

  • 15.1. US
  • 15.2. China

16. Buying Criteria

17. Market Growth Drivers

18. Drivers and their Impact

19. Market Challenges

20. Impact of Drivers and Challenges

21. Market Trends

22. Trends and their Impact

23. Vendor Landscape

  • 23.1. Competitive Scenario
    • 23.1.1. Key News
    • 23.1.2. Mergers and Acquisitions
  • 23.2. Market Share Analysis 2013
  • 23.3. Other Prominent Vendors

24. Key Vendor Analysis

  • 24.1. Abbott Laboratories
    • 24.1.1. Key Facts
    • 24.1.2. Business Overview
    • 24.1.3. Business Segmentation by Revenue
    • 24.1.4. Business Segmentation by Revenue 2011 and 2012
    • 24.1.5. Geographical Segmentation by Revenue
    • 24.1.6. Business Strategy
    • 24.1.7. Key Information
    • 24.1.8. SWOT Analysis
  • 24.2. Alere
    • 24.2.1. Key Facts
    • 24.2.2. Business Overview
    • 24.2.3. Business Segmentation by Revenue 2013
    • 24.2.4. Business Segmentation by Revenue 2012 and 2013
    • 24.2.5. Geographical Segmentation by Revenue 2013
    • 24.2.6. Business Strategy
    • 24.2.7. Recent Developments
    • 24.2.8. SWOT Analysis
  • 24.3. Ortho-Clinical Diagnostics
    • 24.3.1. Key Facts
    • 24.3.2. Business Overview
    • 24.3.3. Key Developments
    • 24.3.4. SWOT Analysis
  • 24.4. Roche Diagnostics
    • 24.4.1. Key Facts
    • 24.4.2. Business Overview
    • 24.4.3. Business Segmentation by Revenue 2013
    • 24.4.4. Geographical Segmentation by Revenue 2013
    • 24.4.5. Business Strategy
    • 24.4.6. Recent Developments
    • 24.4.7. SWOT Analysis

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Cardiac Biomarkers Market 2013-2018 (US$ million)
  • Exhibit 3: Global Cardiac Biomarkers Market Segmentation by Type of Assay
  • Exhibit 4: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2013 & 2018 (US$ million)
  • Exhibit 5: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2013
  • Exhibit 6: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2018
  • Exhibit 7: YoY Growth Rate of Global Cardiac Biomarkers Market Segments by Type of Assay 2013-2018
  • Exhibit 8: Global Cardiac Biomarkers Market Segmentation Snapshot by Type of Assay
  • Exhibit 9: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2013-2018 (US$ million)
  • Exhibit 10: Global Cardiac Biomarkers Market Segmentation by Type of Assay 2013-2018
  • Exhibit 11: Characteristics of Cardiac Biomarkers
  • Exhibit 12: Global Troponin Assay Market 2013-2018 (US$ million)
  • Exhibit 13: Global BNP & NT-proBNP Assay Market 2013-2018 (US$ million)
  • Exhibit 14: Global CK-MB Assay Market 2013-2018 (US$ million)
  • Exhibit 15: Global Myogloblin Assay Market 2013-2018 (US$ million)
  • Exhibit 16: Global Cardiac Biomarkers Market Segmentation by End-user
  • Exhibit 17: Global Cardiac Biomarkers Market Segmentation by End-user 2013 & 2018 (US$ million)
  • Exhibit 18: Global Cardiac Biomarkers Market Segmentation by End-user 2013 (Revenue)
  • Exhibit 19: Global Cardiac Biomarkers Market Segmentation by End-user 2018 (Revenue)
  • Exhibit 20: Global Cardiac Biomarkers Market Segmentation by End-user 2013-2018 (US$ million)
  • Exhibit 21: Global Cardiac Biomarkers Market Segmentation by End-user 2013-2018
  • Exhibit 22: YoY Growth Rate of Global Cardiac Biomarkers Market Segments by End-user 2013-2018
  • Exhibit 23: Global Cardiac Biomarkers Market Segmentation Snapshot by End-user
  • Exhibit 24: Global Cardiac POC Testing Market Segmentation by Assay Type
  • Exhibit 25: Global Cardiac POC Testing Market Segmentation by Assay Type 2013
  • Exhibit 26: Global Cardiac POC Testing Market Segmentation by Assay Type 2018
  • Exhibit 27: Global Cardiac POC Testing Market Segmentation by Assay Type 2013-2018 (US$ million)
  • Exhibit 28: Global Cardiac POC Testing Market Segmentation by Assay Type 2013-2018
  • Exhibit 29: Global Cardiac POC Testing Market Segmentation Snapshot by Assay Type
  • Exhibit 30: Global Cardiac POC Testing Market 2013-2018 (US$ million)
  • Exhibit 31: Global Cardiac POC Testing Market by Geographical Segmentation 2013
  • Exhibit 32: Global Cardiac POC Testing Market by Region/Country 2013
  • Exhibit 33: Global Troponin Market in POC Setting 2013-2018 (US$ million)
  • Exhibit 34: Global BNP & NT-proBNP Market in POC Setting 2013-2018 (US$ million)
  • Exhibit 35: Global Cardiac Laboratory Testing Market Segmentation by Assay Type
  • Exhibit 36: Global Cardiac Laboratory Testing Market 2013
  • Exhibit 37: Global Cardiac Laboratory Testing Market 2018
  • Exhibit 38: Global Cardiac Laboratory Testing Market 2013-2018 (US$ million)
  • Exhibit 39: Global Cardiac Laboratory Testing Market 2013-2018
  • Exhibit 40: Global Cardiac Laboratory Testing Market Segmentation Snapshot by Assay Type
  • Exhibit 41: Global Cardiac Laboratory Testing Market 2013-2018 (US$ million)
  • Exhibit 42: Global Cardiac Laboratory Testing Market by Geographical Segmentation 2013
  • Exhibit 43: Global Troponin Market in Laboratory Setting 2013-2018 (US$ million)
  • Exhibit 44: Global BNP & NT-proBNP Market in Laboratory Setting 2013-2018 (US$ million)
  • Exhibit 45: Global Cardiac Biomarkers Market by Geographical Segmentation 2013
  • Exhibit 46: Global Cardiac Biomarkers Market by Region/Country 2013
  • Exhibit 47: Geographical Segmentation of Global Cardiac Biomarkers Market by End-user 2013
  • Exhibit 48: YoY Growth Rate of Regions/Countries in Global Cardiac Biomarkers Market by End-user 2013-2018
  • Exhibit 49: Cardiac Biomarkers Market in the Americas 2013-2018 (US$ million)
  • Exhibit 50: Cardiac Biomarkers Market in the US 2013-2018 (US$ million)
  • Exhibit 51: Cardiac Biomarkers Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 52: Cardiac Biomarkers Market in Europe 2013-2018 (US$ million)
  • Exhibit 53: Cardiac Biomarkers Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 54: Cardiac Biomarkers Market in China 2013-2018 (US$ million)
  • Exhibit 55: Global Cardiac POC Testing Market Share Analysis 2013
  • Exhibit 56: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 57: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 58: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 59: Alere: Business Segmentation by Revenue 2013
  • Exhibit 60: Alere: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 61: Alere: Geographical Segmentation by Revenue 2013
  • Exhibit 62: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 63: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Back to Top